An interventional study of fresh frozen plasma and blood sample in End Stage Liver DIsease and Liver Transplantation, sponsored by Beijing Chao Yang Hospital. Status unknown at 1 site in China. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-11-24.
Sponsored by Beijing Chao Yang Hospital · Not applicable, Interventional, and Treatment
To study the effects of plasma transfusionon during liver transplantation on endothelial condition and short-term outcome in patients with end-stage liver disease.
266 studies on the registry are indexed under End Stage Liver Disease; 61 are open to participants now.
This study's planned enrollment of 30 is below the median of 70 across 152 interventional studies indexed under End Stage Liver Disease.
Browse End Stage Liver Disease studies →Beijing Chao Yang Hospital is the lead sponsor of 139 studies on the registry; 50 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
perform artificial colloidal solution transfusion during anhapetic phase.
Diagnostic Test: blood sample
Perform plasma transfusion during anhapetic phase.
Biological: fresh frozen plasma · Diagnostic Test: blood sample
perform plasma transfusion in different phases during perioperation
get blood samples at several specific points in time during perioperation
endothelial glycocalyx layer shedding markers
plasma concentration of endothelial glycocalyx layer shedding markers
Time frame: 24 hours
inflammatory cytokines
levels of inflammatory cytokines
Time frame: 24 hours
Plan to share: No
No publications or documents are linked to this record.
This study is status unknown, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Human plasma